Section 22-A3416. MEDICATION/SOMATIC TREATMENT

 

3416.1Medication/Somatic Treatment services are medical interventions including physical examinations; prescription, supervision or administration of mental- health related medications; monitoring and interpreting results of laboratory diagnostic procedures related to mental health-related medications; and medical interventions needed for effective mental health treatment provided as either an individual or group intervention.

 

3416.2Medication/Somatic Treatment services include monitoring the side effects and interactions of medication and the adverse reactions which a consumer may experience, and providing education and direction for symptom and medication self-management.

 

3416.3Group Medication/Somatic Treatment services shall be therapeutic, educational and interactive with a strong emphasis on group member selection, facilitated therapeutic peer interaction and support as specified in the IRP/IPC.

 

3416.4Each Medication/Somatic Treatment provider shall offer a comprehensive psycho-educational program for consumers and families, as appropriate, regarding the consumer's mental illness, emotional disturbance or behavior disorder, treatment goals, potential benefits and risk of treatment, self-monitoring aids, and consumer/family groups for education, support, and enhancement of the therapeutic alliance between the consumer and the MHRS provider.

 

3416.5 Consumers receiving Medication/Somatic Treatment shall participate in a psychoeducational session to discuss medication side effects, adverse reactions to medications, and medication self-monitoring and management at the following times:

 

(a) During development of the IRP/IPC;

 

(b) In conjunction with the one hundred eighty day (180) day IRP/IPC review; and

 

(c) At any time the consumer’s medications are changed.

 

3416.6All consumers receiving Medication/Somatic Treatment services shall be evaluated on the Abnormal Involuntary Movement Scale (AIMS) annually, and the results of the AIMS testing shall be incorporated into the medication assessment and treatment planning process for each consumer receiving Medication/Somatic Treatment.

 

3416.7Medication/Somatic Treatment shall be provided with no annual limits on service.

 

3416.8Medication/Somatic Treatment shall not be billed on the same day as ACT.

 

3416.9Medication/Somatic Treatment shall be provided:

 

(a)At the MHRS provider's service site;

 

(b)In natural settings, including the consumer's home or other community setting; or

 

(c)A residential facility of sixteen (16) beds or less.

 

3416.10Qualified practitioners of Medication/Somatic Treatment are:

 

(a)Psychiatrists;

 

(b)APRNs; and

 

(c)RNs.

 

authority

The Director of the Department of Mental Health (Department), pursuant to the authority set forth in sections 104 and 105 of the Department of Mental Health Establishment Amendment Act of 2001, effective December 18, 2001 (D.C. Law 14-56; D.C. Official Code § 7-1131.04 and 7-1131.05).

source

Final Rulemaking published at 48 DCR 10297 (November 9, 2001); as amended by Final Rulemaking published at 51 DCR 9308 (October 1, 2004); as amended by Final Rulemaking published at 52 DCR 5682 (June 17, 2005); as amended by Notice of Emergency and Proposed Rulemaking published at 58 DCR 1482 (February 18, 2011)[EXPIRED]; as amended by Notice of Final Rulemaking published at 58 DCR 3476, 3478 (April 22, 2011).